10.6084/m9.figshare.c.3617414_D1.v1
Birgit EngesĂŚter
Birgit
EngesĂŚter
Bianca van Diermen Hidle
Bianca
van Diermen Hidle
Mona Hansen
Mona
Hansen
Pia Moltu
Pia
Moltu
Kjersti Staby
Kjersti
Staby
Siri Borchgrevink-Persen
Siri
Borchgrevink-Persen
Olav Vintermyr
Olav
Vintermyr
Stefan LĂśnnberg
Stefan
LĂśnnberg
Mari NygĂĽrd
Mari
NygĂĽrd
Emiel Janssen
Emiel
Janssen
Philip Castle
Philip
Castle
Irene Christiansen
Irene
Christiansen
Additional file 1: Table S1. of Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study
Springer Nature
2016
Human papillomavirus
HPV
Cervical cancer screening
HPV primary screening
HPV testing
Quality assurance
Cobas 4800 HPV Test
Inter-laboratory reproducibility
2016-11-24 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Table_S1_of_Quality_assurance_of_human_papillomavirus_HPV_testing_in_the_implementation_of_HPV_primary_screening_in_Norway_an_inter-laboratory_reproducibility_study/4382534
Ct-values for HPV and beta-globin detection in samples with discordant results. The Ct-values of the discordant samples were generally above 38.4 (with two exceptions), and hence close to the clinical Ct cut-off values. The Ct-values of beta-globin were for all samples between 25.5 and 28, indicating sufficient quality of the input DNA. (DOCX 18 kb)